We are using cookies on this website. We assume your consent, as you are making use of this website. A cookie is a simple small file sent with the pages of this website and stored by your browser on the hard disk of your computer. The stored information can be resent to our servers the next time you visit the website. More information
Accept
Sysmex Europe
Sysmex Europe
Other Sites
Menu

December - Emulsion PCR for highly sensitive detection of tumour mutations in peripheral blood

The BEAMing technology involves conversion of single DNA molecules to single magnetic beads, each containing thousands of copies of the sequence of the original DNA molecule. The number of variant DNA molecules in the population can be assessed by staining the beads with fluorescent probes and counting them by using flow cytometry. This way OncoBEAM® blood-based tests deliver a minimally invasive alternative for sensitive real-time molecular diagnostics to improve cancer characterisation and treatment.

Copyright © Sysmex Europe GmbH. All rights reserved.